I'm following Steve's nose on this one. I suspect they decided...

I'm following Steve's nose on this one.

I suspect they decided to publish the 4C on Monday to ensure an orderly market.

Today's rise wouldn't be from name dropping Walmart.

When MedAdvisor was an AU name only, the circle was small.

MDR now has employees elsewhere doing their own sums, so I hope it's a bumper September quarter.

If you Google the two US names, you'll find a very recent article suggesting Walmart (and CVS and Walgreens and Giant Eagle) has contributed to the opioid crisis.

Lembke also testified that Walmart and Giant Eagle pharmacies worked with a company called Adheris Wealth Health to help ensure patients continued taking and refilling their opioid prescriptions.

Patients targeted by the so-called “prescription adherence program” were 5.2 percent more likely to remain on their prescriptions and 1.4 percent more likely to take on a new prescription, according to Lembke.

“When it comes to opioids, you don’t need and shouldn’t have adherence programs; opioids sell themselves,” Lembke said. “The real challenge is getting patients who have been on opioids off of them again.”

I'm not sure blaming pharmacies for the opioid crisis is the right approach. It's like blaming AusPost for drugs being delivered through their network or an ISP for people illegally downloading movies. And the statements above appears to suggest "adherence programs are successful". The issue is complex. Big pharma is both friend and foe to the healthcare industry.

Perhaps today's announcement is a PSA.

Regardless, I'm hoping there is momentum into next week after today's action/volume/news and the 4C numbers.

Today is #freedomfriday (in VIC).

Looking forward to #medadvisormonday.